Koller M - Search Results

1

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

Brashear A, Lew MF, Dykstra DD, Comella CL, Factor SA, Rodnitzky RL, Trosch R, Singer C, Brin MF, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M. Brashear A, et al. Among authors: koller m. Neurology. 1999 Oct 22;53(7):1439-46. doi: 10.1212/wnl.53.7.1439. Neurology. 1999. PMID: 10534248 Clinical Trial.

2

Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.

Lew MF, Adornato BT, Duane DD, Dykstra DD, Factor SA, Massey JM, Brin MF, Jankovic J, Rodnitzky RL, Singer C, Swenson MR, Tarsy D, Murray JJ, Koller M, Wallace JD. Lew MF, et al. Among authors: koller m. Neurology. 1997 Sep;49(3):701-7. doi: 10.1212/wnl.49.3.701. Neurology. 1997. PMID: 9305326 Clinical Trial.

3

Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.

Cullis PA, O'Brien CF, Truong DD, Koller M, Villegas TP, Wallace JD. Cullis PA, et al. Among authors: koller m. Adv Neurol. 1998;78:227-30. Adv Neurol. 1998. PMID: 9750919 Clinical Trial. No abstract available.

4

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.

Brin MF, Lew MF, Adler CH, Comella CL, Factor SA, Jankovic J, O'Brien C, Murray JJ, Wallace JD, Willmer-Hulme A, Koller M. Brin MF, et al. Among authors: koller m. Neurology. 1999 Oct 22;53(7):1431-8. doi: 10.1212/wnl.53.7.1431. Neurology. 1999. PMID: 10534247 Clinical Trial.

5

BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).

Truong DD, Cullis PA, O'Brien CF, Koller M, Villegas TP, Wallace JD. Truong DD, et al. Among authors: koller m. Mov Disord. 1997 Sep;12(5):772-5. doi: 10.1002/mds.870120526. Mov Disord. 1997. PMID: 9380065

6

A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.

Sheremata WA, Vollmer TL, Stone LA, Willmer-Hulme AJ, Koller M. Sheremata WA, et al. Among authors: koller m. Neurology. 1999 Mar 23;52(5):1072-4. doi: 10.1212/wnl.52.5.1072. Neurology. 1999. PMID: 10102433 Clinical Trial.

7

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.

Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: koller m. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.

8

Preliminary effectiveness of social prescription and virtual patient information in increasing tertiary prevention among cancer patients (ESPRIT): protocol for a single-centre, randomised controlled pilot trial.

Boyer L, Bernardi C, Leitzmann M, Koller M, Pukrop T, Einhell S, Heudobler D, Steindorf K, Herr W, Herrmann A. Boyer L, et al. Among authors: koller m. BMJ Open. 2025 Jan 20;15(1):e087177. doi: 10.1136/bmjopen-2024-087177. BMJ Open. 2025. PMID: 39832968 Free article. Clinical Trial.

9

Outcome of Patients Transplanted for C3 Glomerulopathy and Primary Immune Complex-Mediated Membranoproliferative Glomerulonephritis.

Halfon M, Taffé P, Bucher C, Haidar F, Huynh-do U, Mani LY, Schachtner T, Wehmeier C, Venetz JP, Pascual M, Fakhouri F, Golshayan D; Swiss Transplant Cohort Study. Halfon M, et al. Kidney Int Rep. 2024 Oct 15;10(1):75-86. doi: 10.1016/j.ekir.2024.10.008. eCollection 2025 Jan. Kidney Int Rep. 2024. PMID: 39810762 Free PMC article.

10

Validation of biomarkers and clinical scores for the detection of uterine leiomyosarcoma: a case-control study with an update of pLMS.

Vollmer M, Köhler G, Radosa JC, Zygmunt M, Zimmermann J, Köller M, Seitz C, Bralo H, Radosa MP, Kaya AC, Krichbaum J, Solomayer EF, Kaderali L, Alwafai Z. Vollmer M, et al. Among authors: koller m. BMC Cancer. 2025 Jan 8;25(1):33. doi: 10.1186/s12885-024-13396-y. BMC Cancer. 2025. PMID: 39773707 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,186 results

Search Page

Filters